The Week in Review: September 22 – September 29, 2017

Friday, September 29, 2017 News Recap: Merck discontinues HCV programs. There were rumours, but now it’s official: Merck has announced that it will discontinue the development of the investigational combination regimens MK-3682B (grazoprevir/ruzasvir/uprifosbuvir) and MK-3682C (ruzasvir/uprifosbuvir) for the treatment of chronic hepatitis C virus (HCV) infection. In a statement the company said the decision was made based on a review of available Pha...

Canada’s nurses applaud billions in savings found in PBO report on pharmacare

OTTAWA, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Canadian Federation of Nurses Unions (CFNU) President, Linda Silas, responded to the Parliamentary Budget Office’s (PBO) costing document on the establishment of a national pharmacare program, commissioned by the Commons Health Committee and released today. “Beyond a shadow of a doubt, the PBO report confirms for Canadians that a national pharmacare program will generate substantial savings – in the order of bill